Percutaneous vertebroplasty is a treatment for painful osteoporotic compression fractures. Multiple reports have shown as high as 20 % refracturerates in vertebrae adjacent to those that have been treated with percutaneous vertebroplasty. The purpose of the study is to determine if prophylactic vertebroplasty of unfractured vertebrae adjacent to the treated fractured vertebrae can reduce the rates of refracture in adjacent vertebrae.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
100
PMMA injection 3-10 milliliter in each treated vertebrae
Nevroradiologisk avdeling Ullevål universitetssykehus HF
Oslo, Oslo County, Norway
Refracture rate based on MRI and CT after 3 months and one year
Time frame: 3 months and one year
Pain relief after the procedure based on VAS
Time frame: 3 months and one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.